• CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
  • Fanconi Anemia Type C Gene Mutation Analysis
  • Mercury, Blood
  • CD4 Lymphocyte Count
  • Ganglioside (GM1) Antibody, IgG and IgM
  • Sarcoma Gene Mutation, Fusion and Rearrangement Panel, NGS
  • Desipramine, Serum
  • Ulcerative colitis
  • Chromosome Analysis, Interphase, FISH
  • Acid Phosphatase, Total, Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Prosigna Breast Cancer Prognostic Gene Signature
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Prosigna Breast Cancer Prognostic Gene Signature
Medical Test

Additional Testing
Access to Prosigna Breast Cancer Prognostic Gene Signature is restricted.